Brevan Howard Capital Management LP Macrogenics Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Macrogenics Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 41,706 shares of MGNX stock, worth $134,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,706
Previous 21,522
93.78%
Holding current value
$134,710
Previous $91,000
50.55%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MGNX
# of Institutions
132Shares Held
55.4MCall Options Held
215KPut Options Held
238K-
Bellevue Group Ag Kuesnacht, V89.93MShares$32.1 Million0.55% of portfolio
-
Armistice Capital, LLC New York, NY6.26MShares$20.2 Million0.34% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$17.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$14.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$11.4 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $199M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...